Nuclear DUX4 immunohistochemistry is a highly sensitive and specific marker for the presence of CIC::DUX4 fusion in CIC-rearranged sarcomas: a study of 48 molecularly confirmed cases.

MLA

Macedo, Rodrigo T., et al. “Nuclear DUX4 Immunohistochemistry Is a Highly Sensitive and Specific Marker for the Presence of CIC::DUX4 Fusion in CIC-Rearranged Sarcomas: A Study of 48 Molecularly Confirmed Cases.” Histopathology, vol. 86, no. 3, Feb. 2025, pp. 423–32. EBSCOhost, https://doi.org/10.1111/his.15341.

APA

Macedo, R. T., Baranovska-Andrigo, V., Pancsa, T., Klubíčková, N., Rubin, B. P., Kilpatrick, S. E., Goldblum, J. R., Fritchie, K. J., Billings, S. D., Michal, M., Švajdler, M., Kinkor, Z., Michal, M., & Dermawan, J. K. (2025). Nuclear DUX4 immunohistochemistry is a highly sensitive and specific marker for the presence of CIC::DUX4 fusion in CIC-rearranged sarcomas: a study of 48 molecularly confirmed cases. Histopathology, 86(3), 423–432. https://doi.org/10.1111/his.15341

Chicago

Macedo, Rodrigo T, Vira Baranovska-Andrigo, Tamás Pancsa, Natálie Klubíčková, Brian P Rubin, Scott E Kilpatrick, John R Goldblum, et al. 2025. “Nuclear DUX4 Immunohistochemistry Is a Highly Sensitive and Specific Marker for the Presence of CIC::DUX4 Fusion in CIC-Rearranged Sarcomas: A Study of 48 Molecularly Confirmed Cases.” Histopathology 86 (3): 423–32. doi:10.1111/his.15341.